[Outcome of therapy in ALL in children].
D000135:Acid Phosphatase / Q000378:metabolism; D001215:Asparaginase / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000556:secondary; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007945:Leukemia, Lymphoid / Q000532:radiotherapy / Q000628:therapy*; D008199:Lymphadenitis / Q000209:etiology; D011379:Prognosis; D012306:Risk; D013601:T-Lymphocytes / Q000201:enzymology
D003561:Cytarabine; D000135:Acid Phosphatase; D001215:Asparaginase
Therapieergebnisse bei ALL im Kindesalter.